chr9-78300646-TG-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_058179.4(PSAT1):c.107delG(p.Gly36fs) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000417 in 1,608,416 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000040 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000042 ( 0 hom. )
Consequence
PSAT1
NM_058179.4 frameshift
NM_058179.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 8.42
Genes affected
PSAT1 (HGNC:19129): (phosphoserine aminotransferase 1) This gene encodes a member of the class-V pyridoxal-phosphate-dependent aminotransferase family. The encoded protein is a phosphoserine aminotransferase and decreased expression may be associated with schizophrenia. Mutations in this gene are also associated with phosphoserine aminotransferase deficiency. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene have been defined on chromosomes 1, 3, and 8. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-78300646-TG-T is Pathogenic according to our data. Variant chr9-78300646-TG-T is described in ClinVar as [Pathogenic]. Clinvar id is 1081.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSAT1 | NM_058179.4 | c.107delG | p.Gly36fs | frameshift_variant | 2/9 | ENST00000376588.4 | NP_478059.1 | |
PSAT1 | NM_021154.5 | c.107delG | p.Gly36fs | frameshift_variant | 2/8 | NP_066977.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSAT1 | ENST00000376588.4 | c.107delG | p.Gly36fs | frameshift_variant | 2/9 | 1 | NM_058179.4 | ENSP00000365773.3 | ||
PSAT1 | ENST00000347159.6 | c.107delG | p.Gly36fs | frameshift_variant | 2/8 | 1 | ENSP00000317606.2 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151730Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
6
AN:
151730
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248002Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 133976
GnomAD3 exomes
AF:
AC:
3
AN:
248002
Hom.:
AF XY:
AC XY:
2
AN XY:
133976
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000419 AC: 61AN: 1456686Hom.: 0 Cov.: 32 AF XY: 0.0000428 AC XY: 31AN XY: 724316
GnomAD4 exome
AF:
AC:
61
AN:
1456686
Hom.:
Cov.:
32
AF XY:
AC XY:
31
AN XY:
724316
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151730Hom.: 0 Cov.: 31 AF XY: 0.0000540 AC XY: 4AN XY: 74066
GnomAD4 genome
AF:
AC:
6
AN:
151730
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
74066
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Neu-Laxova syndrome 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 23, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1081). This variant is also known as c.delG107. This premature translational stop signal has been observed in individual(s) with phosphoserine aminotransferase deficiency (PMID: 17436247). This variant is present in population databases (rs774147367, gnomAD 0.004%). This sequence change creates a premature translational stop signal (p.Gly36Alafs*7) in the PSAT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PSAT1 are known to be pathogenic (PMID: 17436247, 25152457). - |
PSAT deficiency Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2007 | - - |
not provided Other:1
not provided, no classification provided | in vivo;research | Dudley Research Group, Pacific Northwest Research Institute | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at